Investor directoryNewton Biocapital
Newton Biocapital leverages strong ties to life sciences ecosystems in Europe and Japan to unlock unique investment opportunities.
What they invest in
Sectors
Geographies
EuropeJapan
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Brussels, Belgium
- Founded
- 2017
Portfolio companies
More portfolio companies
Accutar BiotechAbolerIS PharmaCellaïonChromacurePRISM BioLab (TKS: 206A)EditForceActicor BiotechJ-Pharma (TKS: 520A)Synergia MedicalEpics TherapeuticsNeuVasQ BiotechnologiesSantero TherapeuticsTensegrity PharmaDeuterOncologySANTERODim3
Recent rounds
Augustine Therapeutics NV
€77.7MSeries AHealthTechNovo HoldingsleadJeitoleadNewton BiocapitalAsabys PartnersAdBio partnersPMV · +4 more in the source
Belgiumsiliconcanals.com
Rounds Newton Biocapital took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Newton Biocapital typically invest?
- Newton Biocapital states a typical cheque of €1M – €30M.
- Which stages does Newton Biocapital invest in?
- Newton Biocapital invests at Seed, Series A and Series B.
- Where is Newton Biocapital based?
- Newton Biocapital is headquartered in Brussels, Belgium.
Does Newton Biocapital fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Newton Biocapital? Tell us what to correct and we will update it — or ask us to remove the entry.